Savings totaled $293 billion in 2018.
What execs and experts think of the future of drug costs.
A cure and a bargain?
Results from a new Massachusetts Health Policy Commission report.
Specialty pharmacy has reached an “inflection point” with the power to change the entire industry model.
Finalized rule is a step toward increasing drug pricing transparency.
Rebates for prescription drugs are under scrutiny and attack in both the political and healthcare arenas. But what will happen if drug rebates go away?
The average price of generics is about one-eighteenth the price of the brand product.
Advocates are calling for government regulations on PBMs and pharmacy.
Aggregated data highlights manufacturers responsible for price increases.